Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Celecoxib × 90 days × Clear all

Sponsor

Conditions

Medulloblastoma 3 Rhabdoid Tumor 2 Recurrence 2 Pinealoma 2 Neuroblastoma 2 Ependymoma 2 Solid Tumor 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pyloric Stenosis, Hypertrophic 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Histiocytosis, Langerhans-Cell 1 Glioma 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Rituximab 21 Cyclophosphamide 11 Lenalidomide 9 zanubrutinib 7 venetoclax 6 orelabrutinib 6 obinutuzumab 6 fludarabine 6 pirtobrutinib 4 fludarabine phosphate 4 Vincristine 4 Prednisone 4 Magnetic Resonance Spectroscopy 4 CT-P10 4 Bendamustine Hydrochloride 4 ibrutinib 3 Whole-Body Irradiation 3 Specimen Handling 3 Doxorubicin 3 acalabrutinib 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Cyclosporine 2 Biopsy 2 voruciclib 1 umbralisib 1 treosulfan 1 tislelizumab 1 tafasitamab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡